CHAI negotiates a 67 percent price reduction for service and maintenance of the first point-of-care CD4 diagnostic tool, called Pima, for HIV. CHAI accelerates the market entry of a second supplier, called BD FACS Presto, which will facilitate further price reductions for point-of-care CD4 tests.